FDA Approves Alzheimer’s Patch
The FDA has approved the first transdermal patch for the treatment of Alzheimer’s dementia. The drug rivastigmine, known by the prescription brand Exelon , has been available since 1997 in capsule and in tablet form, but only now has the drug been approved by the FDA as